Research programme: single dose hepatitis B vaccine - N4 Pharma
Alternative Names: HBsAg vaccineLatest Information Update: 06 Jun 2018
At a glance
- Originator N4 Pharma
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Hepatitis B
Most Recent Events
- 18 May 2018 Suspended - Preclinical for Hepatitis B (Prevention) in United Kingdom (Parenteral) (N4 Pharma pipeline, May 2018)
- 17 May 2018 Preclinical trials in Hepatitis B (Prevention) in United Kingdom (Parenteral) before May 2018 (N4 Pharma pipeline, May 2018)